SSHA

Society of Sexual Health Advisers

Unite the union
  • About us
    • JOIN SSHA
    • Code of Professional Conduct
    • National Organising Professional Committee
    • National Organising Professional Committee Structure
    • Constitution and Rules
    • Council Reports
    • NPC ACCESS ONLY
  • News
  • Regions
    • London
    • North East, Yorkshire & Humberside
    • Ireland
    • Scotland
    • South West
    • East Midlands – VACANT
    • North West
    • South East
    • Wales
    • West Midlands
  • Resources
    • I Want To Be A Health Adviser
    • SSHA Manual
    • Conference Presentations
    • Competency Framework for Sexual Health Advisers
    • WeSSI: West Sussex Sexual Health Structured Interview
    • Research
    • Unite – Union
    • Publications
  • Jobs
    • Current Jobs
    • Sample Job Descriptions
  • Links
Home » PrEP HIV drugs: court hears NHS England appeal

PrEP HIV drugs: court hears NHS England appeal

September 16, 2016 By SSHA Leave a Comment

prep_ssha

NHS England is appealing high court ruling it has power to commission ‘game-changing’ prevention strategy

A legal battle is being fought out in the court of appeal over who pays the bill for a service to block HIV infection.

The high court ruled that NHS England has the power to commission PrEP, which has been described as a “game changer” in the fight against HIV/Aids.

NHS England is appealing on the grounds that local authorities have the legal responsibility to arrange services to “prevent” the spread of HIV, while its own responsibilities are limited to treating those already assumed to be infected.

PrEP, short for “pre-exposure prophylaxis”, is a prevention strategy which involves people who are HIV negative but at high risk of infection taking the anti-retroviral drug Truvada to reach optimal levels of protection.

The anticipated cost of providing PrEP services is £10m-£20m a year.

When taken consistently, it has been shown to reduce the risk of HIV infection in people who are at high risk by more than 90%.

The legal battle is both important and urgent because of its potential impact on the provision of other services, including hearing implants for children with deficient or missing auditory nerves, prosthetics for lower limb loss, and a drug for treating certain mutations in children aged two to five with cystic fibrosis.

Nine new treatments and services NHS England had planned to make available to patients have been put on hold pending the outcome of the appeal.

In May this year, NHS England’s specialist services commissioning committee decided not to commission PrEP, saying it lacked power to do so under NHS legislation and regulations.

But Mr Justice Green, sitting in London’s high court, ruled on 2 August that it did have the power under the NHS Act 2006 and under regulations made in 2012 which came into effect in April 2013. The ruling was a victory for leading charity the National Aids Trust (NAT) with backing from the Local Government Association (LGA).

Jonathan Swift QC, appearing for NHS England, is asking the appeal judges – Lord Justice Longmore, Lord Justice Underhill and Lady Justice King – to rule the high court decision wrong in law and to conclude that provision of PrEP services does indeed fall outside NHS England’s legal powers.

Swift said the case was a matter of general public importance because it involved the balancing of the division of health responsibilities between NHS England, the health secretary and local authorities. The QC drew a distinction between “PrEP” and “PEP”. He said NHS England has provided PEP – the post-exposure prophylactic service – since 2013.

He described PEP as an emergency service provided in cases where there was “an assumption” that the person being treated was “HIV infected” at the time of treatment – in contrast to PrEP, which was for people “not infected”.

Mr Swift argued the 2012 regulations only required NHS England to provide services, such as PEP, for patients already believed to be infected.

Responsibility for funding PrEP fell to local authorities since they were under an express obligation to make arrangements for services to prevent the spread of sexually transmitted infections, including HIV. The high court judgment which is being challenged said the case was about “the allocation of budgetary responsibility in the health field”.

Mr Justice Green said: “No one doubts that preventative medicine makes powerful sense. But one governmental body says it has no power to provide the service and local authorities say they have no money.

“The claimant is caught between the two and the potential victims of this disagreement are those who will contract HIV/Aids but who would not were the preventative policy to be fully implemented.

“In my judgment the answer to this conundrum is that NHS England has erred in deciding that it has no power to commission the preventative drugs in issue.”

Alternatively, said the judge, NHS England has “mischaracterised the PrEP treatment as preventative when in law it is capable of amounting to treatment for a person with infection”. In any event NHS England had the power to commission preventative treatments because that facilitated, or was incidental to, “the discharge of its broader statutory functions”.

NHS England is asking the appeal court to rule the high court wrong on all counts. Campaigners have said that while the majority of gay men use condoms to prevent being infected with HIV, there is also an “ethical duty” to provide PrEP to those who do not. And they say the drug would provide an additional defence against HIV, and would not be used simply as an alternative to safe sex.

Press Association
Thursday 15 September 2016
Article Link

Filed Under: Latest SSHA News, Media Watch Tagged With: High Court, hiv, Jonathan Swift QC, Justice Green, Lady Justice Kings, lga, Local Government Association, Lord Justice Longmore, Lord Justice Underhill, NAT, national aids trust, nhs england, prep, truvada

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About SSHA

The Society of Sexual Health Advisers (SSHA) is a UK national organisation with approximately 300 members out of an estimated 350 sexual health advisers in the country. It provides an opportunity for members to meet and work towards further professional development.

Recent Posts

  • Helping People to Reduce Sexual Health Risk: A Motivational Interviewing Approach February 28, 2023

Useful Links

  • BASHH
  • HPV Action
  • NAM
  • Public Health England
  • Public Health Scotland
  • Terence Higgins Trust
  • UNITE the Union

Copyright © 2023 · SSHA - Society of Sexual Health Advisers

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT